Femme et Homme
- | Pays :
- France
- Belgium
- Czech Republic
- Les 7 autres...
- | Organes : -
- | Spécialités : -
Extrait
The objective of this dose-ranging study is to determine the effects of several intravenous (IV) regimens of otamixaban on pharmacodynamic markers (including markers of thrombosis and coagulation markers), safety/tolerability, clinical efficacy and pharmacokinetics.
Critère d'inclusion
- Angioplasty, Transluminal, Percutaneous Coronary